H3k27m Mutation - Cancer Science

Relevant Publications

Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges.

Issue Release: 2024

Blood and cerebrospinal fluid biomarkers in neuro-oncology.

Issue Release: 2024

Very Long-Term Survivorship in Pediatric DIPG: Case Report and Review of the Literature.

Issue Release: 2024

PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo.

Issue Release: 2024

EZHIP\'s role in diffuse midline glioma: echoes of oncohistones?

Issue Release: 2024

Ascites production and prognosis after ventriculoperitoneal shunt for diffuse midline gliomas in children: A case series.

Issue Release: 2024

An E2 ubiquitin-conjugating enzyme links diubiquitinated H2B to H3K27M oncohistone function.

Issue Release: 2024

Deep mutual learning on hybrid amino acid PET predicts H3K27M mutations in midline gliomas.

Issue Release: 2024

H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.

Issue Release: 2024

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors.

Issue Release: 2024

H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells.

Issue Release: 2024

High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.

Issue Release: 2024

Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma.

Issue Release: 2024

The immune response behind peptide vaccination in diffuse midline glioma.

Issue Release: 2024

Primary spinal cord gliomas: Pathologic features associated with prognosis.

Issue Release: 2024

Case Report: Low-grade glioma with loss of function mimicking diffuse intrinsic pontine glioma.

Issue Release: 2024

H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition.

Issue Release: 2024

Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma.

Issue Release: 2024

H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Issue Release: 2024

Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.

Issue Release: 2024

What Role Do Quality Assurance and Calibration Play?

How Does Food Sourcing Impact Cancer Risk?

How is Mass Spectrometry Used in Cancer Research?

What is Revlimid (Lenalidomide)?

What is the Transcription Initiation Complex?

What is Clinical Data Integration?

What is the Role of SWCNTs in Drug Delivery?

What is Access to Cancer Care?

What Role Do Public Health Initiatives Play?

How Can Publication Rates Be Improved in Under-Researched Areas?

Partnered Content Networks

Relevant Topics